UK Public Sector Contracts & Tenders

The delivery of Specialist Hospice and End of Life Care services including CYP Services IPU, Hospice at Home, Bereavement services, 7 days care after death of child PLUS CYP Hospice at Home / Community - EPIC PLUS East Anglia Children's Hospices (EACH) Core CYP Hospice Services within NHS Mid and South Essex, North East Essex and West Essex geographies.

The delivery of Specialist Hospice and End of Life Care services including one response service, South Essex Lymphoedema Service, CNS Palliative Care Teams, Specialist Occupational Therapy, Advanced Care Planning, End of Life (EoL) Facilitators, Frailty and Care Home Support Service within NHS Mid and South Essex.

The delivery of Specialist Hospice and End of Life Care services including IPU, Hospice at Home, Bereavements Services within NHS Mid and South Essex.

The delivery of Specialist Hospice and End of Life Care services including IPU, Hospice at Home, Bereavements Services within NHS Mid and South Essex.

The delivery of Mental Health Services for Adults and Infant Mental Health Service for the patient population within Mid and South Essex.

The delivery of General Acute Services to patients within Essex. General Acute Services including Accident and Emergency Services (A+E), Acute Services, Ambulance Services, Cancer Services, Diagnostic, Screening and/or Pathology Services, End of Life Care, Patient Transport, Radiotherapy, Urgent Treatment, Routine Elective Care, Elective Care, Critical Care Service, Fragility, Electroencephalography, Podiatry, Audiology and Respiratory Services.

Commissioners in Mid and South Essex wish to provide their patients with a choice of providers who can deliver high quality elective care in accordance with the terms of this agreement and in particular all relevant Guidance. The service provided under this notice will be for Elective Services under patient choice provision. The services being commissioned are: 1. General Ophthalmology Services 2. Glaucoma Services 3. AMD Services 4. Cataract Services This contract award has been made following Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023 and the Public Contract Regulations 2015 (as amended) do not apply. The contract is awarded with no guarantee of activity. The value will vary dependent upon the activity delivered and tariff is reflective of National Tariff Payment System (NTPS) The services will be delivered from the following ACES site: - Chelmsford

Following publication of a voluntary ex ante transparency notice on the 19th January and conclusion of the 10 days standstill period the Mid and South Essex Integrated Care Board's (hereinafter referred to as "the Authority") is to award a contract (for reasons of extreme urgency brought about by events unforeseeable by the Authority), to award a contract for Internal Audit, Counter Fraud and Security Management Services under Regulation 32 (2) (c) to TIAA Limited for a period of 24 months commencing 1st April 2024 with the option to extend for a further 12 months. The Authority have observed a 10-day standstill from the date of publication of the VEAT.

The service provided under this notice will be for Elective Services under patient choice provision. This contract award has been made following Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023 and the Public Contract Regulations 2015 (as amended) do not apply. The contract is awarded with no guarantee of activity. The actual contract value will vary dependent on the activity delivered. Therefore, this notice outlines a total contract value of £1.00. The indicative aggregate contract value for the most recent contractual year was £10,551,958.00

The service provided under this notice will be for Elective Services under patient choice provision. This contract award has been made following Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023 and the Public Contract Regulations 2015 (as amended) do not apply. The contract is awarded with no guarantee of activity. The actual contract value will vary dependent on the activity delivered. Therefore, this notice outlines a total contract value of £1.00. The indicative aggregate contract value for the most recent contractual year was £19,307,216.

The service provided under this notice will be for Elective Services under patient choice provision. This contract award has been made following Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023 and the Public Contract Regulations 2015 (as amended) do not apply. The contract is awarded with no guarantee of activity. The actual contract value will vary dependent on the activity delivered. Therefore, this notice outlines a total contract value of £1.00. The indicative aggregate contract value for the most recent contractual year was £5,125,742.00

The service provided under this notice will be for Elective Services under patient choice provision. This contract award has been made following Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023 and the Public Contract Regulations 2015 (as amended) do not apply. The contract is awarded with no guarantee of activity. The value will vary dependent upon the activity delivered. The indicative value for the most recent contractual year was £14,993,621 The services will be delivered from the following sites: Spire Wellesley Hospital

The provider is an existing provider, who is currently satisfying the requirements of the existing contract. The provider has been assessed against the criteria specified for this DAP C process: Quality & Innovation 20%. Value 20%. Integration, Collaboration & Service Sustainability 20%, Access Health Inequalities and Choice 20%; Social Value 20%. Key criteria were specified, and assessment against each criterion was assessed based on the current service delivery model and performance. and the supplier meets all the requirements specified to the satisfaction of the ICB, and it is expected that they will satisfy the requirements of the new contract.

The service provided under this notice will be for Elective Services under patient choice provision. This contract award has been made following Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023 and the Public Contract Regulations 2015 (as amended) do not apply. The contract is awarded with no guarantee of activity. The value will vary dependent upon the activity delivered. The indicative value for the most recent contractual year was £3,334,828 The services will be delivered from the following Circle sites: - Southend Hospital

The service provided under this notice will be for Elective Services under patient choice provision. This contract award has been made following Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023 and the Public Contract Regulations 2015 (as amended) do not apply. The contract is awarded with no guarantee of activity. The actual contract value will vary dependent on the activity delivered. Therefore, this notice outlines a total contract value of £1.00. The indicative value for the most recent contractual year was £557,287. The services will be delivered from the following Circle sites: • Blackheath Hospital • London Independent Hospital • Kings Oak and Cavell Hospital • Southend Private Hospital

This is a voluntary ex ante transparency notice and is intended to provide notice of the Mid and South Essex Integrated Care Board's (hereinafter referred to as "the Authority") intention (for reasons of extreme urgency brought about by events unforeseeable by the Authority), to award a contract for Internal Audit, Counter Fraud and Security Management Services under Regulation 32 (2) (c) to TIAA Limited for a period of 24 months commencing 1st April 2024 with the option to extend for a further 12 months. The Authority will observe a 10-day standstill from the date of publication of this VEAT, during which the ICB will not enter into any contractual arrangement.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Integrated Primary Community Care (IPCC) Severe Mental Illness (SMI) for Mid and South Essex to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037534) on the 20th December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The contract will be for 12 months from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £1,329,439.00 The Authority has taken the decision to award this IPCC SMI to incumbent provider Vita Health Group. The provider is considered most technically capable of providing the most economically advantageous solution to the Authority under the current environment whilst the ICB undergoes restructure, review and alignment of contracts. The Authority is applying the NHS Standard Contract Terms and Conditions to support a combination of services, all of which are part funded under a single clinical contract, to ensure appropriate clinical governance and service delivery quality as well as consistency of service to patients.

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Dermatology Services to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months, from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £809,230. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037586) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.)

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Gynaecology and Urology Provision to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037591) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (“PCR 2015”) (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The contract will be for 12 months, from 01st April 2024 - 31st March 2025. The aggregate contract value is forecasted at £688,146.00